N
Google TrendSOX SCORE (1000+) — MLB playoffs 2026: Inside White Sox's postseason pitching plan
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:sox score1000+bill maher500+ben simmons500+lisa200+sherrod brown1000+mn gophers2000+will venable1000+kalshi1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Does Patient Selection In" (30 stories)

Top Headline Story

Does Patient Selection Inflate CAR T Outcomes in Multiple Myeloma?
Lead StoryCancerNetworkpolitics
Aug 9

Does Patient Selection Inflate CAR T Outcomes in Multiple Myeloma?

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNNDgweUxiUXNQbFV3QlA2cWxBTjFGdWIxMWs5RWJpWFFfTVllNW1oeFdsVUJNNmQtV0xLa1FmYkhWM194cXlRRnJaWjNGVmxqekJPbXFaem1VSnpsYkJfMGc0WFIwMnd3ZS1BTGx5SENrdy0zVExRN016Z29OQ3BkNHN5S3BZQzNfMlNvREl0aWthc05jMTlHRUY4NkxxVTBFelpF?oc=5" target="_blank">Does Patient Selection Inflate CAR T Outcomes in Multiple Myeloma?</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
1000+24m ago

sox score

MLB playoffs 2026: Inside White Sox's postseason pitching plan

Filter stories
500+24m ago

bill maher

Michael Douglas Tells Bill Maher About Smuggling Marijuana in Suitcases, Slams ‘Nepo Baby’ Label

Filter stories
500+24m ago

ben simmons

Ben Simmons to make his Kings debut against Golden State

Filter stories
200+24m ago

lisa

Trump Announces White House Inquiry Into Fed Governor Lisa Cook

Filter stories

Search Results for "Does Patient Selection In"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
AI in clinical trials: Patient selection, adaptive design, and the translational gap
Drug Discovery Newstech

AI in clinical trials: Patient selection, adaptive design, and the translational gap

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNbnAyVUxOMTRLUTY5cVVRb0FfdDNYclp6RXkwZ3RoTVhIZHBaUVlzWm8zblVnc2xRbTJvYmZ3TWdpZTFNUVVTa0RkTXZ5TWxXdm5hakVhSHljRF9tXzFvZWI3U3lvWTdING90al90Z0lReDFmSGlvZkxsZEc4dVl0cHBXSVgxci05NE50NFVEZWtucW5xeDFyMnpmU1M2a1ZXOF9SYlJGUU9LOHFGRHY4c1JFQlZ5eGpqbURWWjF3?oc=5" target="_blank">AI in clinical trials: Patient selection, adaptive design, and the translational gap</a>  <font color="#6f6f6f">Drug Discovery News</font>

Read Full StoryMore like this
HoLEP patient selection and the technical error most surgeons make past training
Urology Timestech

HoLEP patient selection and the technical error most surgeons make past training

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNUEJLY0xRY2RQMWFjY3pIYjQtTzRjeE1QX0k0d3l1RVpzRkdjT3J3Q2lTTXpIdU8xMElTTjNzM1ozU0pVS2VWc0pPOFNXeDBvdVRtMHYzYnZzZkpZc1BteWxtdEZaZG5hSmxKeTFrTEVmMll6TjNYcGZobTZqWnY3UExPck5zRER2dldNN1d5RXBVQXRGeTFpZGZzeGFUdWlkQmtlQ1g1dlZEVVVCdWdyUmNRS28?oc=5" target="_blank">HoLEP patient selection and the technical error most surgeons make past training</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
De-escalation in HER2+: Oral Regimens, Toxicity, and Patient Selection
DocWireNewspolitics

De-escalation in HER2+: Oral Regimens, Toxicity, and Patient Selection

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPcVZQcklENF92R3Z1UFBTWXdTckNsNWhGbUxnWnRJaWFySjl4S3F0Z3c0Q1F1OUZSYW1IZkt1c3ZnVGRMRVRzNzVQbzlwTjY4OVd5cU5HbFdvdWhnVDZISEhTVnl6bTJwa0dIUlRvbGl1M0xHcDN4RnlzZ0xSYUJBMkFxbTNESnc4MnN1S1hOQkQ4dVBMQktZTm9kYkE1ZDAxXzFB?oc=5" target="_blank">De-escalation in HER2+: Oral Regimens, Toxicity, and Patient Selection</a>  <font color="#6f6f6f">DocWireNews</font>

Read Full StoryMore like this
Optimizing Bulking Agents in Stress Urinary Incontinence: Patient Selection, Technique, and Outcomes - Christopher Chermansky
UroTodaytech

Optimizing Bulking Agents in Stress Urinary Incontinence: Patient Selection, Technique, and Outcomes - Christopher Chermansky

<a href="https://news.google.com/rss/articles/CBMisAJBVV95cUxNclpyMGFFQ0RfcHI4cjRCWGtrWGtBMlVHTkFLVHVuc0lLXzhXV3JUb2NGT0pjNy1UakJmc00zalRrUzJNbTJReUZ6T0psZTFiMHVIUVZOOVpnQ2ZCQmwxeUFPMXVGMzNJS3J3S294UzJnNlV3NHJQdkNLN1VWSlZvcndBWGh2V0N6LU5WV2ZHMnJsYU9mM2lrM2xWRWQzR2J0RXB3Y0hQU2xKLVpMRVV3SzcxTHVyV2RPVXdhdklFS2MyLVJJRnlSQU0zV0tmMjJYdUo0NDBwVmp3d0JYUUdwSTVMa2JpZUpkRGxLdmFPdFpDbndoQXMyenRhS2wwMEdrZV9GNkIxUXNpeE5mcC1tdjZtSzVZa0dkNzNsVlhaYkVuRGIzR0dpUk9LQUtYOWM1?oc=5" target="_blank">Optimizing Bulking Agents in Stress Urinary Incontinence: Patient Selection, Technique, and Outcomes - Christopher Chermansky</a>  <font color="#6f6f6f">UroToday</font>

Read Full StoryMore like this
NT-proBNP can help identify feline heart disease, but patient selection matters
DVM 360politics

NT-proBNP can help identify feline heart disease, but patient selection matters

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxON3FIM21rc0JQdVN4TTZXTmE1MW1peDVXOFFXVW0ycTRZX1ltcDFDN3lJVjhWVjhaaVhwMlhFeDF6OENOb3dkWHBmWVBKSzFUNFRlRXBDRDNSSXQxbm8zNW5CbkdueGtfaVBONGVta2VkWnBjVy0zNWlXN3YzMkxRMS1WZThyQmRwbmp4aE5YaXRYM3d1T29NWS1Jb3ZPMTBfeG9IMG1RRDNVZw?oc=5" target="_blank">NT-proBNP can help identify feline heart disease, but patient selection matters</a>  <font color="#6f6f6f">DVM 360</font>

Read Full StoryMore like this
CHAMPION-AF and the Future of Stroke Protection: Rethinking Left Atrial Appendage Closure and Patient Selection in Atrial Fibrillation
HMP Global Learning Networkpolitics

CHAMPION-AF and the Future of Stroke Protection: Rethinking Left Atrial Appendage Closure and Patient Selection in Atrial Fibrillation

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQb2pxQnl1TTdZZWNQTTBhdHFETF9fY3V1QUJIUFUtZGxQeXRmRTEzM2pSN2hQMk9iQTlRWURuMmM1NVRwMG5tbklYeE1wZ0dfTnloOHJfM2FhT0h3UVBXLUxQSHNyY1lJNzBlV1JoWmNmZEtzZ2JNNmR2VGdGMGlOOHFiU05QS3U3eDFEalAwNHFONEY3TTB2OTB6UGhfbDRiYXotZGZBdWU2S2lWN2NLMThiRVZYQUlYdkFPWTFGa1V6ci1OQU5pVHF1OXpCUQ?oc=5" target="_blank">CHAMPION-AF and the Future of Stroke Protection: Rethinking Left Atrial Appendage Closure and Patient Selection in Atrial Fibrillation</a>  <font color="#6f6f6f">HMP Global Learning Network</font>

Read Full StoryMore like this
Opinion: Patient choice matters
Concord Monitorgeneral

Opinion: Patient choice matters

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQcXh0TmZhaUtDU2JVSGFsNUQ4RTVfMDNJU1ppU0V6QW5MMTlVZUhFWi1faXVHVnhvQi1OX2E1VlI1ZUNkamJPRmhZbS1reWVCa25rVmtvSXRuRElRakplX2dxakFNbUc3RmVjNEQteWxtNnhwSkYxSG1rQkRSTUVVb05tdnJMX3dseTlzOHNjdy1CYWNqY3c?oc=5" target="_blank">Opinion: Patient choice matters</a>  <font color="#6f6f6f">Concord Monitor</font>

Read Full StoryMore like this
Radioligand Therapy and Patient Selection Criteria for Lu-PSMA-617 - Phillip Koo
UroTodaypolitics

Radioligand Therapy and Patient Selection Criteria for Lu-PSMA-617 - Phillip Koo

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxPTDV3Z2FwNEJNbTRydUlpN0xhM3lRNjVuOEVBd01NaTVvTGNLZFk0TlRvTHRwTnhWa256dFR1ODJhbGs4VVhaWFhoSUZxTmRPQWx1OXZMSmJvMHF5Z0hNWTd3Wkd4T254RmRRcVJEWmQydnBTNHhleTR6TGY2LXY4SUVxNDJvdnhrM1RTSm1iTHIzMEtJVmJteXllQzNRS0VwcS1UNjlZYzJqYzlQXzQtb2J2T3JrMWdUQlV4QWg3UXh4cUhmQ3lWYXpfT2RpdU9IYnpkbW50dWl0TXF6MTg4N0k1Z2U?oc=5" target="_blank">Radioligand Therapy and Patient Selection Criteria for Lu-PSMA-617 - Phillip Koo</a>  <font color="#6f6f6f">UroToday</font>

Read Full StoryMore like this
Savitha Krishnan, MD, discusses patient selection for robotic sacrocolpopexy
Urology Timespolitics

Savitha Krishnan, MD, discusses patient selection for robotic sacrocolpopexy

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNS29VN21KSFJIYS1lMjVvSWpuMGFybGR1Rmk4WUtyakUxcXBMbTJnY3JTZEJ3eTFYS0I5ZzBTZzY5bi1ZTWVFTW9QQVFKWkpqTkRzby1Ud2h2aWhlSy1UOFNMUG1sVnZVbXhmeWJPdER6UTdZdXhNNjA0NG9oMVNCZmdsM1ZkN09xUjRicnEzdHY3U0VCRGJSdzBFRnR0R3JfZlZrUnVDblhTbU9V?oc=5" target="_blank">Savitha Krishnan, MD, discusses patient selection for robotic sacrocolpopexy</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Health Bill: What does it mean for Patient Choice?
Burges Salmonpolitics

Health Bill: What does it mean for Patient Choice?

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNQWpOOUNFZmxPRXQ5Vm1jUUhmeXY3YV9mbjh1cm9ldUEtNzQzUHhSNGYzd1FuNzl3YXdESDBFeFVDQzhQN21NSy10cUVzQzlCaWNacUpBWTRSUFpOYVkyRkZWeWJReDZpbkFVMEZkaU1BQmJYTHNoTXFvQVB2NzRiN3BCV2pyUEJfeFhWWTZNZXFkVUo0eFU0QU5NcGU?oc=5" target="_blank">Health Bill: What does it mean for Patient Choice?</a>  <font color="#6f6f6f">Burges Salmon</font>

Read Full StoryMore like this
Radiopharmaceuticals in Prostate Cancer Part 3A: Patient Selection and Treatment Sequencing - Tanya Dorff, Neal Shore & Dustin Boothe
UroTodaypolitics

Radiopharmaceuticals in Prostate Cancer Part 3A: Patient Selection and Treatment Sequencing - Tanya Dorff, Neal Shore & Dustin Boothe

<a href="https://news.google.com/rss/articles/CBMizwJBVV95cUxPU1d0VEwxcWpoVV85eXFUazlQUjFMN3RzQnVVX25uN2VQMUpvWW5qX0kwTVdnd1liZDdtbk9qdnRfa3pULWNsU0dsMXZHOWtFVVRFcE1lY2hBMDBPR0ZoNUpGUzZYVWhnVG44dXRfU2xlR0dEY3dOZVJFWl9OVHd1d0lzTlo2aU5xeVcyYWF3X0dkZ014YjV4MWJxMzFlSEIzMmYxd2VFeGh6VUtsTXdaR1ZJaXF5TWhrZ2c3R1dNempZZVNPZTlmRnYzaTRQdUE2WGczRURtRlQ1dVNvVTFuSklDVkh5RVhVZGxzMHJZVmszSGJhZDh1QXRBaEU5X1g4X3U5amZlcktrSkZTYXZYVFl6TzZLNVd4dG83d2h4TGJwSUFlY1BuSUNrblMwWm1KckJYSjkwelVicDE4TlFPbHVLNUdydXpOZnc3QzVLUQ?oc=5" target="_blank">Radiopharmaceuticals in Prostate Cancer Part 3A: Patient Selection and Treatment Sequencing - Tanya Dorff, Neal Shore & Dustin Boothe</a>  <font color="#6f6f6f">UroToday</font>

Read Full StoryMore like this
Anesthetics in status epilepticus: does one size fits it all?—A scoping review on titration goals, timing, and patient selection
Frontierspolitics

Anesthetics in status epilepticus: does one size fits it all?—A scoping review on titration goals, timing, and patient selection

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOaDAyRzcxLXJ3TF9aVnJSRDF4MUM5aUJVRDBzeXBNc3hiZGl6X3AyZHA4TDBvVk5yNHZEM29DMEhsY25zbHRfc0ZBMUJrbXhsQjlxWGJFUWQxNWt5ZE1tSDU3T055Q1gwVTl6NzJRMUhfRXdvYzNQTjZ6SWNwdmFsdkpWc1hpdC1QZlpjQzk0cGQ?oc=5" target="_blank">Anesthetics in status epilepticus: does one size fits it all?—A scoping review on titration goals, timing, and patient selection</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
ACCESS: A Fix For Digital Health Companies, Not Medicare’s Costliest Patients
Health Affairsscience

ACCESS: A Fix For Digital Health Companies, Not Medicare’s Costliest Patients

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQWFp4MGNOaFlWa2JCdHhrZzhnTkFPWjNqakpfeUE4ZXNaeUR3dlhFeEhRVlZuRjk2U3owSk1sS29WMXlxVjFWSU4xNjlZazhydGQ2NFFzQk1SWEtuVEJuTWo4UU5CaWVsNGFWRFVUWVFkcGUyNVZ1dVJFZkhvdmxnZ0lUMmdrb1RoTnFRSVBEeVp5Q19TLVlCb2RlQTVKY2pJcWJUajBDZ1Z5a05BbGpkSHpwT05TeWx0?oc=5" target="_blank">ACCESS: A Fix For Digital Health Companies, Not Medicare’s Costliest Patients</a>  <font color="#6f6f6f">Health Affairs</font>

Read Full StoryMore like this
Case 1: RCC With Disease Progression After Adjuvant Pembrolizumab
The ASCO Postgeneral

Case 1: RCC With Disease Progression After Adjuvant Pembrolizumab

<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxOVG5zSWJIRVlmOUpFbmJNLTNHUlQxajJuQk1DbVA4NUhFd2djaklQaXhPS2hqU29mRm5VdURFdi02Q2liVS05d25MYkJ6NU52MHViTGJ0ZmtJY3JvZEdmM1owUFRIaVNYMnlfN0NIdUlWQXBNeXpxZWU1S2FpTExLbVRtcWppOC0wREppMWdqWEFUR0JoMDNEUVF3dVc2cHVFSFVMUElqbmV3cEdTcWZOSmQxeTR0UWcxRDAtZmNJU3BvQ3FCY2hqOGoteFVZZkQ5dkZFb3hnWnp0RU9TTWtCM0xRcXo0R01RYjdhbF9YX09XQ2hO?oc=5" target="_blank">Case 1: RCC With Disease Progression After Adjuvant Pembrolizumab</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Patient Preferences, Expected Toxicity Serve As Guiding Factors for Frontline Chemo Selection in Pancreatic Cancer
OncLivepolitics

Patient Preferences, Expected Toxicity Serve As Guiding Factors for Frontline Chemo Selection in Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxPejZtY3J3WUJiX01WRUhBM0tUQm80N0JRV1h3UVp6Vy1Wa2MxeEZRRm9RS0lDeFhsUUtGU0VZTDFWeXA3dmdQSlNXT3JuS2U5ZDZTbFBBWDNoSmZzcHEtSkVfeFRLQ2RVODAyUXdFUTB4ejBwclRZQTROU1NlMnlQb3djOUh3V3NTcFUzSjRnWG5FVjk3X05iaUM1MkQ2aGhiR2VBVDRkUW5rOThwYmh0dUx3WDVha3BtX3ZUdnBPem1sSk1IX0tqcWM5bTlIbTdGVkJPcS1CS2pUQQ?oc=5" target="_blank">Patient Preferences, Expected Toxicity Serve As Guiding Factors for Frontline Chemo Selection in Pancreatic Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
The Cost and Trust Factors Driving Patient Choice in Post-Acute Care: U.S. News 2026 Survey
US News Healthgeneral

The Cost and Trust Factors Driving Patient Choice in Post-Acute Care: U.S. News 2026 Survey

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPZGdZeWw3WTgySnB5MTlXNm1hcDE5d1dWdEcwd1piaVFqQWFzb1BzYk1rekhTb3VncW1hTjFhTWYxb1FSVnlVQTJEOEstaGJWTFVVR3JSbDR6ZFRyMGUyTi01Yzg2bVg1bG0yR3o4Qmh0cGcyZWdnSzBybXhld1V0ZnZ2S3BENloya2hhVTcwdWJDNU1JRUxn?oc=5" target="_blank">The Cost and Trust Factors Driving Patient Choice in Post-Acute Care: U.S. News 2026 Survey</a>  <font color="#6f6f6f">US News Health</font>

Read Full StoryMore like this
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer
Naturepolitics

HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA4aDRCTU0zVDdDYm9BT3AzcHdQUGx0S0ZzVHFWb3FMZHNIV2dyWDQ2TW9HNjB3UXItYnhUUm5takp4SmZLaHVRelU2X0oxaEI5QjdDRmUzUjZDX0wxR0NV?oc=5" target="_blank">HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
OncLivepolitics

Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQRTJ4c1NQTHRUakhHUTN0QmItMzNnczZiaVBTVUg1TGxfeG93ZHlkSzVzZmNuUENZa3FzYUlsS3pZbWtFWGs5WUUtTW1uc1ZnOUdoTzAyUVlvZzNQZnc2QWN6LWxCS1pGLVB0ejlwZ2QyOTRFajBmVDVIVjd2OThxa2p6aVgxZEFza1FSMERyWWljOWo0cXlYVHlad3VQNGNsWk8zSG1XVDRndW14VzZmZ2JBay15eEZCbjJJQTMtWFBxMExxNTlOVW9n?oc=5" target="_blank">Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Patient Goals and Concomitant Needs Help Guide TKI Selection in CML
OncLivepolitics

Patient Goals and Concomitant Needs Help Guide TKI Selection in CML

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPV2hkVzN6aTRBWEF4cE9wZ1Q5OWdQR2tlRWZvWFg5MGxiRTBhQ0NTSkZ6SXNUOGNsb2RsdmJFSTlxam1sREZPMTNkTld6X2M3d3FTSGNCaWg0R2FiT1lkYVNwbEMxS0R4bkE3YU1pMU5aejVsVElJeDZ5dXlDbEs0RXpWbU1UNmVaUW9NRGNqY195Sm04c3VMc0FoRW8?oc=5" target="_blank">Patient Goals and Concomitant Needs Help Guide TKI Selection in CML</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Patient Selection Is Crucial for Treatment Decisions in Metastatic Melanoma After PD-1 Inhibition
OncLivepolitics

Patient Selection Is Crucial for Treatment Decisions in Metastatic Melanoma After PD-1 Inhibition

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNdF9YdmxJcmEyN05URC14VDZ5YWlaQXVyUndKel9hOHhwd3FVLWRlWUlCRXBiQi00WFpEb29aa3lxLTE3QWhyckxMZnVsbUt0UEsyemlGZE5qOXN6NTJmbndLSE9FUVdNYUEwNnpYTWktbWVqMFQ2UTUyRGdBdkw2MWtvOEJoNHpnZ1ZJRHk3Qy1tTlVNUk9JM2ZkeUdhcndMMXh5SE1BNnhYdE1kX0hxNTM0aEpHZw?oc=5" target="_blank">Patient Selection Is Crucial for Treatment Decisions in Metastatic Melanoma After PD-1 Inhibition</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Practical Application and Patient Selection for PRRT
HMP Global Learning Networkpolitics

Practical Application and Patient Selection for PRRT

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQaUVXOTY0THVySEZ2MGdfQnNyaWRRbmhzYjV2elNJMU1XaVpZeUhFMlVMVnhFcEpUMThqbVFFV3oyMVJhYUx0OHZDT0w0RlNUNnNpUlZzU2d5V3ItaXhzcGNxN0lORS1BSnNFaWVOZHVRQVhuWEdvd0c4N24zQ0ZkWWlqSU9YMWFzUE53dDNtemFQaDVudnpoLUdzUzhiVFM2TG9TeXR0TE8?oc=5" target="_blank">Practical Application and Patient Selection for PRRT</a>  <font color="#6f6f6f">HMP Global Learning Network</font>

Read Full StoryMore like this
Patient selection for cytoreductive nephrectomy in 2025
Urology Timespolitics

Patient selection for cytoreductive nephrectomy in 2025

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxORzBVRnQtNUJOZ3g4TW9DbV8xSFNuWVpXV0ZlNF9jX1FaeFNSTjJHcHAzaVpXN2hlenFNeDI1SUg1X19TRWRjTXIyaDA5YjJ0SVJjdlFZTzFLUDdWU3ZDY0U3ZTRWRVFzZzdvTk1rNDZRQ2oybG45b0NwWlBkeGs4cEtqVUY3U2VIWVZVWEdadW1XWHM?oc=5" target="_blank">Patient selection for cytoreductive nephrectomy in 2025</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Considerations for Patient Selection in PSMA Radioligand Therapy - Scott Tagawa & Alan Bryce
UroTodaypolitics

Considerations for Patient Selection in PSMA Radioligand Therapy - Scott Tagawa & Alan Bryce

<a href="https://news.google.com/rss/articles/CBMi_gFBVV95cUxNX0MtbDRoR2U1WGxta2I2MXBQSDNtbUxXQm1hcnl5d29Ya0U0SktCWGZmcFlQVm9MVnFIYnNnWFM4bl9McTdHWUxMcFFucGo3SUN6WlFhanNXSlQxQWlLSkFWVGZLZlRpOTJ6Q1hBdEs1WmVrT1BaQzJyeVN1d3AxOWJtei1TcTBDUC1JOVNxMkZPOWNaOUJhNzRNMVplcWZPeGp1b3B2dUphSFlQcGJRSGN0eEVYQ0xvNUpleHpGR3VUM2ZzZFpwS2d2STJtVnRSbHBUN3Nxb1UxN09Cbl9sYnpmaG5RcmROMXhnTU1xQVRFbUtXQ0xGMlJQQVJ1dw?oc=5" target="_blank">Considerations for Patient Selection in PSMA Radioligand Therapy - Scott Tagawa & Alan Bryce</a>  <font color="#6f6f6f">UroToday</font>

Read Full StoryMore like this
Inside HoLEP: Irina Jaeger, MD, discusses patient selection and technique
Urology Timestech

Inside HoLEP: Irina Jaeger, MD, discusses patient selection and technique

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPM3JEcnc4SGpEeEVrS3ZYSWp5dWQ3VmVDSFA1bGtoQlRudG5DTXMzbWRkcFdpVVlhNHpiYnlSd0hXeFpFb1dyaXByYlg0OEp6aFBPRVJmeDRtMkxjZmgycjR6emlXQ0hHeXlldFNNY1QxVjE1MERjNk5ndFAwZEFfZzJJRmM3aFp1cE1aQy1sT0xtZk5IUTVtcHZCWlFocHE0WkZxdzBtVQ?oc=5" target="_blank">Inside HoLEP: Irina Jaeger, MD, discusses patient selection and technique</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Patient Selection and Outcomes for Partial Cystectomy in Muscle-Invasive Bladder Cancer - Wei Shen Tan
UroTodaypolitics

Patient Selection and Outcomes for Partial Cystectomy in Muscle-Invasive Bladder Cancer - Wei Shen Tan

<a href="https://news.google.com/rss/articles/CBMijAJBVV95cUxPS2R2N1F1T3pzSlNlS2JZaV9taG1wNFctWEFHSTVrUXM5RzR6cVpGUW4tdnVRU0c2TUJUX3FPTHR2MkNLMVNsWDg3eVZ5QlBjNjlhRXY1R2RkRUg2ZC1vSU1zSkh2RmRvc1RHcjRublZEbHJJSVNIX2xlRHMxVFVlUjFHOUVZbTJ1ZzA1c2VOSU5WMGJqZFRrLWNKamI5X25TSVhKMHdPSi1DTGstR0ZVQlQ4dlExdDU0LUI0Ym9ubkdQdGhiSE00V0NmcGlOLXJGaVJBQm43VHIyTF81M19NNnh5MmxNQ3NhNVUyOGd1RE5zN1kxT2hnRU1TV2xTVTlScExvY3R1S205NGNG?oc=5" target="_blank">Patient Selection and Outcomes for Partial Cystectomy in Muscle-Invasive Bladder Cancer - Wei Shen Tan</a>  <font color="#6f6f6f">UroToday</font>

Read Full StoryMore like this
Precision Oncology in NSCLC: Overcoming Patient Selection Barriers
AJMCpolitics

Precision Oncology in NSCLC: Overcoming Patient Selection Barriers

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNVXl4MjN3TGZjZXBoUnlzSHZfMi0zcXh1UUZOcXpMY2dmcmhWbmZ3cWVQNlRPVDdSaEgtYmNSNzA4NER2SEMyMzRBb3NwbER0TkZLeUpFT2pIcV9FZFJraW11Wjh3Rzg4YU5pZm9fb0psdF80OVZtVjJQRDN1Nm9oLXRNMU93SzA0aWVnWWR0UkRfWFhfa2c?oc=5" target="_blank">Precision Oncology in NSCLC: Overcoming Patient Selection Barriers</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryMore like this
Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection
Naturepolitics

Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBzRWIweTBJTVdsNGwyWjZneWF5QnhlWnpDV0JfMmlCQnZTd3JBMU1hVXJkV3FKbUtXbi1OLVBacDRwNkRZaVZIT2hrY01rOFBCa19NUnlBSG0xclJHWjdF?oc=5" target="_blank">Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Careful patient selection required for same-day discharge after BPH procedures
Urology Timespolitics

Careful patient selection required for same-day discharge after BPH procedures

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxObk5lOFdNWWdDdGdkQl9kMldneUQtQ1ExNVdhbjhPWmREaDN0bGF6SUlMYVZOcV84TlEyaDk0dkEyQ1FyNXlNaURIRVJhUVQ5b0J4ZHc4YUtvODVZTXIwZ2VGMlVVN2hSSzViQlZmRnpGQ3c5UEdjM2cxRmdtRnlhUlRUZENnU0JPTU1PakVtNFhfbHI3NU5ZcHpxMnVUX05HY0xuZ1pNc0xDX2xaMmFfMWxR?oc=5" target="_blank">Careful patient selection required for same-day discharge after BPH procedures</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Patient-Centered Discussions Will Be Critical to Navigate Treatment Selection in EGFR+ NSCLC
OncLivepolitics

Patient-Centered Discussions Will Be Critical to Navigate Treatment Selection in EGFR+ NSCLC

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQV25Kai1PR3NMdk1EOHFVbEotZ2VUbXZPLW54dzl0SndMRzVsV2FndGwxYi1iVEZIamNOXzUtVVZBU1VmemcwUlUySWhhUEpUNWl6SXg3MVRRYXVFcWt1bktiZndDWjFpYU8tOUhxWThOWlRzdHdsUmpHeUZGQWJRbTB1a2ZHZUFHbmRtU2NWXzEzUjZYMWpocGZlV3Q3a19kdmxWb1RKa2dhajhnWXpIaWhyVnhMcjZjZ0xNcQ?oc=5" target="_blank">Patient-Centered Discussions Will Be Critical to Navigate Treatment Selection in EGFR+ NSCLC</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
"Does Patient Selection In" — Live Google News Trends & Headlines